![](https://www.scra.org/wp-content/uploads/2022/05/ElastrinCheck2-544x272.jpeg)
SC Launch, Inc. Announces Investment in Elastrin Therapeutics
Columbia, SC – South Carolina Research Authority (SCRA’s) investment affiliate, SC Launch Inc., has invested in Elastrin Therapeutics Inc. This $300,000 investment will help the company advance the development of therapeutics that reverse damaged tissue making it supple again. L to R: Dr. Matthias Breugelmans,CEO of Elastrin Therapeutics; Prof. Dr. Naren Vyavahare,CSO of Elastrin Therapeutics; Matt Bell, Director […]